Partners 2020
Promega
Expertise Partner
We share your passion for science. Promega is committed to excellence in developing a broad suite of technologies for oncology. Learn how NanoBRET Target Engagement (TE) technology is being used to quantify live cell target occupancy and drug residence time to all proteins within the KRAS-mapk pathway. This platform allows for determination of intracellular TE for orthosteric and allosteric mapk inhibitors, and can now be applied to query wildtype KRAS and oncogenic KRAS mutants in live cells. Let’s collaborate.
Biodesix®
Expertise Partner
Biodesix® is an experienced partner in the field of blood-based molecular diagnostic testing. Our comprehensive diagnostic testing capabilities help our partners decipher the complexity of cancer by interpreting genomic and proteomic information from both tumor biology and the patient’s immune response. Biodesix enables our partners throughout the discovery, development and commercialization of personalized diagnostics to support new therapies with companion diagnostic strategies.
Foundation Medicine
Exhibition Partner
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
Nanome
Exhibition Partner
Nanome is changing how we understand, design, and interact with science. Nanome’s immersive virtual workspaces allow users to visualize, modify, and simulate chemical compounds, proteins, and nucleic acids to help improve the Drug Discovery process. Our virtual reality platform facilitates effective communication of structural data in drug discovery which has proved beneficial to several pharmaceutical and biotech companies across the globe. This is especially helpful for organizations that are interested in improving their cross-site collaboration.
